Be sure to attend the Product Theaters

Product Theaters offer informative sessions focusing on particular products or a single facet of diabetes. Product Theater sessions do not provide continuing education credit. Lunch will be served at the noon sessions to the first 350 attendees. An afternoon break will be offered to the first 350 attendees at the later sessions. Several states have enacted state regulations prohibiting sponsoring companies from providing any food, beverages and/or meals to healthcare professionals practicing in those states. Please consult your state regulations and ethics laws to see if such prohibition would apply to you.

All events held in the Exhibit Hall.

Ticketing Process

  • Look for the designated CS/PT Ticket Desk in the registration area. At this counter, attendees can obtain tickets to the various events. Note: Attendees are limited to one (1) ticket per event time. Seats are limited, so get your tickets early.
  • If you change your mind about attending, return the ticket to the
  • CS/PT Ticket Desk.
  • Doors will open 10 minutes before the scheduled start time for attendees with a ticket.
  • Starting 5 minutes after the scheduled start time, organizers reserve the right to allow walk-ins to fill vacant seats. At this time, tickets will be voided.
  • If a ticket was not available at the CS/PT Ticket Desk, check at the door 10 minutes prior to the event to see if space is available.

 

Wednesday

11:45 AM – 12:45 PM

PT01: The Critical Role GLP-1 Receptor Agonists play in Addressing the Treatment Goals of Adult Patients With Type 2 Diabetes

Exhibit Hall – Product Theater A
Supported by AstraZeneca

Program will review the role of GLP-1 in Type 2 Diabetes and the clinical data of a GLP-1 receptor Agonist. Additionally, the Program will describe the product formulation and provide information about the largest clinical educator network for healthcare providers and their patients.

12:15 PM – 1:15 PM

PT02: Different Patients, Different Changes, One Customizable Solution: Benefits of MiniMed 530G with Enlite

Exhibit Hall – Product Theater B
Sponsored by Medtronic Diabetes
Supported by Medtronic

Presentation and panel discussion of the MiniMed 530G system, which is comprised of the MiniMed 530G with Enlite, CareLink therapy management software, and the Bayer Contour Next Link meter. The session will highlight all components of the system, including CareLink therapy management software and the exceptionally accurate Bayer CONTOUR NEXT LINK meter. Case studies will be utilized to demonstrate better clinical outcomes and interpretation of Carelink reports. During the session, Bayer Contour Next Link will be featured to showcase its accuracy and incorporation with the MiniMed 530G system.
Francine Kaufman, MD, VP Medical Affairs, Medtronic Diabetes
Solveig Halldorsdottir, PhD, Director, Scientific Affairs, Bayer, Diabetes Care, US
Linda Burkett, MSN, RN, CDE, Medical Affairs Manager, Medtronic Diabetes

Thursday

11:45 AM – 12:45 PM

PT03: Advancing Paradigm Changes in Type 2 Diabetes Management

Exhibit Hall – Product Theater A
Supported by Janssen Pharmaceuticals

This program will cover the following topics regarding a sodium-glucose co-transporter (SGLT2) inhibitor: the role of the kidney in regulation of hyperglycemia in T2DM; the mechanism of action — mediated inhibition of SGLT2 in the proximal convoluted tubule of the kidney; key efficacy and safety data from 2 active-controlled clinical trials; important safety information; and a question-and-answer session. This promotional educational activity is sponsored by Janssen Pharmaceuticals, Inc. It is not certified for continuing medical education.
Davida Krueger, MSN, APN-BC, BC-ADM, Certified Nurse Practitioner, Division of Endocrinology, Diabetes, Bone and Mineral Disease
Virginia Valentine, APRN-CNS, RN, BC-ADM, CDE, FAADE, Clinical Nurse Specialist, Northside Family Medicine
Debbie Hinnen, APRN, BC-ADM, CDE, FAAN, FAADE, Advanced Practice Nurse, Memorial Hospital, University of Colorado Health System

12:15 PM – 1:15 PM

PT04 Oral Health and Diabetes: Improving the Oral Health and Overall Health of Our Patients

Exhibit Hall – Product Theater B
Supported by Colgate-Palmolive Co.

In the past 25 years, an explosion of research demonstrates that patients with diabetes are at a greater risk of developing periodontal disease, and that periodontal disease can impact a patient’s ability to regulate his/her blood glucose. This session will provide an overview of the perio-inflammatory process and diabetes, focusing on the current model of periodontal disease, the host response and the connection between periodontal infection/inflammation and diabetes. The participant will learn how currently available professional and over-the-counter oral care products can play an important role in helping improve a patient’s oral health and his/her diabetes management.
Fotinos S. Panagakos, DMD, PhD, Global Director, Scientific Affairs, Colgate-Palmolive Co.

2:45 PM – 3:45 PM

PT05 Optimizing Therapy and Clinical Outcomes Using Real Time Continuous Glucose Monitoring

Exhibit Hall – Product Theater A
Supported by Dexcom

This highly interactive program will consist of presentations on the evolving standard of care for glucose monitoring, real-time, continuous glucose monitoring (CGM), its affect on glycemic improvement and A1C reduction, as well as its ability to minimize glycemic excursions, focusing on reduced hypoglycemia through improved accuracy and performance. Presentations and case studies of the Dexcom G4 PLATINUM CGM system and software, Dexcom STUDIO™, will illustrate how clinicians use real-time CGM to all type 1 and type 2 patients utilizing intensive insulin therapy, and how clinicians can optimize and/or intensify therapy efficiently and effectively using CGM. Opportunities to trial the Dexcom G4 Platinum will be available prior to and immediately after this program.
Patricia Gaye Knutsen, MSN, ACNS-BC, Program Coordinator, Washington University Diabetes Center
Gary Scheiner, MS, CDE, Owner and Clinical Director, Integrated Diabetes Services
Keri Weindel, MS, RD, CDE, Director, Dexcom

PT06 Meet the New ACCU-CHEK Aviva Expert Meter – the First and Only Stand-Alone Meter with a Built-In Insulin Calculator

Exhibit Hall – Product Theater B
Supported by Roche

When focusing on insulin dosing, it is key to make sure your patient understands the calculations. The new ACCU-CHEK® Aviva Expert blood glucose meter, the first and only stand-alone meter with a built-in insulin calculator, helps simplify the complex calculations needed to deliver precise dosing advice. Now your patients can enjoy the meal without worrying about the math. Join us to learn about this exciting new meter and hear real-life patient case studies. ACCU-CHEK and ACCU-CHEK AVIVA EXPERT are trademarks of Roche. © 2014 Roche. 316-53424-0514
Bruce W. Bode, MD, FACE, Clinical Associate Professor, Atlanta Diabetes Associates
Debbie Hinnen, APRN, BC-ADM, CDE, FAAN, FAADE, Advanced Practice Nurse, Memorial Hospital, University of Colorado Health System

Friday

11:45 AM – 12:45 PM

PT07 Glucose Removal: An SCLT2i Treatment Option for Adults with Type 2 Diabetes

Exhibit Hall – Product Theater A
Supported by AstraZeneca

Program provides an overview of the mechanism of renal glucose removal in Type 2 Diabetes and in SGLT2 inhibitor treatment option that provides significant A1C Reduction with additional benefits of weight and BP reduction.
Charles F. Shaefer, Jr., MD, Clinical Assistant Professor of Medicine, Medical College of Georgia

While every effort is made to ensure the accuracy of data listed here, the publisher cannot be held responsible for errors or omissions.

12:15 PM – 1:15 PM

PT08 Understanding Triglycerides

Exhibit Hall – Product Theater B
Supported by AstraZeneca

This program covers what triglycerides are, why hypertriglyceridemia is detrimental, and guidelines.